Vercoulen, J H, Swanink, C M, Zitman, F G et al. · Lancet (London, England) · 1996 · DOI
This study tested whether fluoxetine (an antidepressant medication) could help people with ME/CFS feel better. Researchers gave 96 patients either fluoxetine or a placebo for 8 weeks and measured changes in fatigue, mood, sleep, and physical activity. The medication did not improve any of these symptoms compared to placebo, whether or not patients were depressed.
This well-designed trial provides high-quality evidence that fluoxetine, despite being commonly prescribed for ME/CFS, does not produce measurable clinical benefit. The finding that antidepressants failed even in depressed ME/CFS patients suggests that depression in this condition may have different biological roots than typical depression, potentially redirecting research and clinical practice toward condition-specific treatments.
This study does not prove that no antidepressant is ever helpful for any ME/CFS patient, only that fluoxetine at 20 mg daily was ineffective in this sample. It also does not establish whether other antidepressants or higher doses might have different effects. The 8-week duration may not be long enough to detect benefits if longer treatment is required.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →